Frontiers in Pharmacology (Jun 2020)

Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study

  • Narmeen Mallah,
  • Narmeen Mallah,
  • Maruxa Zapata-Cachafeiro,
  • Maruxa Zapata-Cachafeiro,
  • Carmelo Aguirre,
  • Carmelo Aguirre,
  • Carmelo Aguirre,
  • Eguzkiñe Ibarra-García,
  • Eguzkiñe Ibarra-García,
  • Itziar Palacios–Zabalza,
  • Itziar Palacios–Zabalza,
  • Fernando Macías-García,
  • J. Enrique Domínguez-Muñoz,
  • María Piñeiro-Lamas,
  • María Piñeiro-Lamas,
  • Luisa Ibáñez,
  • Xavier Vidal,
  • Lourdes Vendrell,
  • Luis Martin-Arias,
  • María Sáinz-Gil,
  • Verónica Velasco-González,
  • Adolfo Figueiras,
  • Adolfo Figueiras,
  • Adolfo Figueiras

DOI
https://doi.org/10.3389/fphar.2020.00860
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundDespite the wide benefits of aspirin and its cost-effectiveness, aspirin prescriptions have been reduced due to idiosyncratic responses in susceptible individuals. Low-dose aspirin and single-nucleotide polymorphisms (SNPs) are independently associated with increased risk of gastrointestinal hemorrhage; however, to-date, no studies investigated the SNP-aspirin interaction effect on upper gastrointestinal hemorrhage (UGIH). Therefore, we aimed to evaluate the role of 25 SNPs in multiple genes involved in platelet activation, angiogenesis and inflammatory response in aspirin-related UGIH.MethodsA multicenter, full case–control study was conducted in patients exposed and unexposed to aspirin. Three hundred twenty-six cases diagnosed with UGIH were matched with 748 controls (1:3) by age, gender, health center, and recruitment date. Only adults of European origin were included. Participants were stratified by aspirin exposure and genotype [(Aspirin(−), wild-type), (Aspirin(+), wild-type), (Aspirin(+), genetic variation), (Aspirin(−), genetic variation)]. For each SNP, the Odds Ratio of UGIH and their 95% confidence intervals were estimated in each subgroup by using the generalized linear mixed models for dependent binomial variables. SNP-aspirin interaction effect was estimated through Relative Excess Risk due to Interaction (RERI) measures.ResultsWe observed two categories of SNPs that might modify the risk magnitude of UGIH in aspirin consumers. Seven SNPs (rs1387180 A > G, rs2238631 T > C, rs1799964 T > C, rs5050 T > C/T > G, rs689466 T > C, rs1799983 T > A/T > G, and rs7756935 C > A) were “positive modifiers” associated with an excess of risk from aspirin exposure and carrying that genetic variation (1.75 ≤ RERI ≤ 4.95). On the contrary, the following nine SNPs (rs2243086 G > T, rs1131882 G > A, rs4311994 C > T, rs10120688 G > A, rs4251961 T > C, rs3778355 G > C, rs1330344 C > T, rs5275 A > G/A > T, and rs3779647 C > T) were “negative modifiers” and associated with a reduced risk in aspirin users (−2.74 ≤ RERI ≤ −0.95). ConclusionThis preliminary study suggests that polymorphisms in genes involved in platelets activity, angiogenesis and inflammatory response might modify the risk of aspirin-related UGIH. Further studies with larger sample size and in different populations are needed to confirm our findings. If confirmed, this might have great impact on public health, thanks to aspirin’s prophylactic properties in diseases of high incidence and severity.

Keywords